Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

US FDA approves donepezil transdermal patch for treatment of Alzheimer disease

Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced on Monday the U.S. Food...

Lawmakers in the U.S. push for a permanent ban on illicit versions of fentanyl

A bipartisan trio of U.S. Congressmen on Monday unveiled new legislation that would permanently ban illicit versions of fentanyl, the powerful synthetic painkiller that...

U.S FDA approves expanded use of Bristol Myers lung cancer medication

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo®(nivolumab) in combination with platinum-doublet chemotherapy for adult patients with resectable...

Pfizer pulls blood pressure med in Canada on carcinogen fears

Pfizer is pulling 15 lots of its long-acting blood pressure med Inderal from Canadian shelves, citing unacceptable nitrosamine levels across a range of product...

EU adopts a common standard for the electronic product information on medicines

The European Medicines Regulatory Network has adopted a Common Standard for the electronic product information (ePI) on medicines in the European Union (EU). The EU...

FDA approves Agios’ mitapivat as first disease-modifying therapy for genetic blood disorder

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced that the U.S. Food and Drug...
spot_img

Expert Articles

spot_img